Development and validation of a novel miRNA classifier as a prognostic signature for stage II/III colorectal cancer

BACKGROUND: The TNM staging remains the gold standard for determining the prognosis of patients with colorectal cancer (CRC), which is inadequate at identifying the subset of high-risk stage II and III patients that have a high potential of developing tumor recurrence and may experience death. Emerg...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Junlan, Wei, Qing, Yang, Muqing, Wang, Xiaodong, Liu, Bin, Li, Jiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246165/
https://www.ncbi.nlm.nih.gov/pubmed/34268360
http://dx.doi.org/10.21037/atm-20-1751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246165/
https://www.ncbi.nlm.nih.gov/pubmed/34268360
http://dx.doi.org/10.21037/atm-20-1751

Ejemplares similares